Circulating T cells to infliximab are detectable mainly in treated patients developing anti‐drug antibodies and hypersensitivity reactions
暂无分享,去创建一个
V. Annese | M. Milla | F. Prignano | A. Matucci | G. Petroni | E. Maggi | S. Romagnani | A. Vultaggio | D. Cammelli | F. Nencini | S. Pratesi